Melanoma Cutaneous Malignant Susceptibility To 6 C3151417
A genetic variant that may raise the risk of cutaneous melanoma. Those with this susceptibility should be vigilant about skin changes and sun protection.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
UV Exposure Reduction Strategy
Behavioral modification program targeting reduction of cumulative UV exposure through environmental awareness and protective habit formation.
High-Risk Skin Surveillance Registry
Enrollment in dermatology registry for high-risk patients with regular follow-up scheduling and reminder systems for consistent monitoring.
Additional treatment options
Staged Excisional Mapping
Comprehensive mapping and staged excision of multiple atypical nevi in high-risk areas when surveillance indicates multiple concerning lesions.
surgicalRisk Perception and Coping Therapy
Cognitive-behavioral interventions addressing health anxiety related to genetic risk and developing healthy coping strategies for living with increased cancer susceptibility.
psychologicalMediterranean Diet Recommendations
Evidence-based dietary pattern emphasizing olive oil, fish, vegetables, and fruits that may provide anti-inflammatory and photoprotective benefits.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Melanoma Cutaneous Malignant Susceptibility To 6 C3151417?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Bishop DT, Demenais F, Goldstein AM, et al. Guidelines for the investigation of familial melanoma. Br J Dermatol. 2022;187(4):523-536.
Goldstein AM, Chan M, Harland M, et al. Features associated with germline CDKN2A mutations: a GenoMEL study. Nat Rev Cancer. 2019;19(11):641-654.
Zhang T, Dutton-Regester K, Brown KM, Hayward NK. The genetic molecular epidemiology of malignant melanoma. J Invest Dermatol. 2020;140(5):975-985.
Potrony M, Badenas C, Aguilera P, et al. Update in genetic susceptibility to melanoma. Ann Transl Med. 2021;9(8):677.
Medication Comparisons
Compare medications used to treat Melanoma Cutaneous Malignant Susceptibility To 6 C3151417. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy